ArticlemedRxiv : the preprint server for health sciences2026
Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma.
Yiyun Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.